| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Belite Bio (NASDAQ:BLTE) is set to give its latest quarterly earnings report on Monday, 2025-11-10. Here's what investors need to know before the announcement.
Analysts estimate that Belite Bio will report an earnings per share (EPS) of $-0.51.
Investors in Belite Bio are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
The company's EPS missed by $0.06 in the last quarter, leading to a 4.65% increase in the share price on the following day.
Here's a look at Belite Bio's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.37 | -0.31 | -0.29 |
| EPS Actual | -0.50 | -0.45 | -0.32 | -0.28 |
| Price Change % | 5.00 | 1.00 | 1.00 | 1.00 |
Shares of Belite Bio were trading at $111.73 as of November 06. Over the last 52-week period, shares are up 39.34%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Belite Bio visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: BLTE
